Related Experiment Videos
A revolution in the treatment of non-Hodgkin's lymphoma
G L DeNardo1, R T O'Donnell, R K Oldham
1University of California, Davis, School of Medicine, Department of Internal Medicine, Sacramento 95618, USA.
Cancer Biotherapy & Radiopharmaceuticals
|June 13, 2000
The use of monoclonal antibodies (MoAbs) for immunotherapy and radioimmunotherapy has ushered in a new era in the treatment of non-Hodgkin's lymphoma.
The use of monoclonal antibodies (MoAbs) for immunotherapy and radioimmunotherapy has ushered in a new era in the treatment of non-Hodgkin's lymphoma.